Brain cancer prediction, particularly in pediatric patients, represents a significant advancement in medical science, leveraging cutting-edge technology to enhance patient care.Recent studies have demonstrated that artificial intelligence (AI) tools are able to outperform traditional methods in accurately predicting relapse risks, specifically for conditions like pediatric gliomas.